ERBB2 and breast carcinoma: In summary, a new Hb-AgNCs@MOF-G nanohybrid was designed to fabricate a label-free electrochemical immunosensor for rapid and sensitive detection of HER2 + breast cancer cells using the “signal off” SWV and “signal on” EIS strategies.